Gritstone bio, Inc.
NASDAQ:GRTS
0.0322 (USD) • At close October 21, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|
Assets: | ||||||||
Current Assets: | ||||||||
Cash & Cash Equivalents
| 65.285 | 55.498 | 93.287 | 170.056 | 57.408 | 52.183 | 39.007 | 12.41 |
Short Term Investments
| 16.288 | 116.389 | 108.346 | 1.002 | 70.368 | 100.927 | 46.946 | 25.097 |
Cash and Short Term Investments
| 81.573 | 171.887 | 201.633 | 171.058 | 127.776 | 153.11 | 85.953 | 37.507 |
Net Receivables
| 0.231 | 0.664 | 2.365 | 0 | 0.482 | 0.462 | 1.71 | 0.171 |
Inventory
| 0 | 3.313 | 15.726 | 0 | 2.725 | 3.615 | 0.721 | 0.599 |
Other Current Assets
| 5.631 | 7.014 | 0.866 | 0.268 | 0.29 | 0.449 | 0.095 | 0.114 |
Total Current Assets
| 87.435 | 182.878 | 220.59 | 175.39 | 131.273 | 157.636 | 88.479 | 38.391 |
Non-Current Assets: | ||||||||
Property, Plant & Equipment, Net
| 84.12 | 38.816 | 44.542 | 43.449 | 50.338 | 29.494 | 27.211 | 7.49 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0.518 | 0.585 | 0.554 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0.518 | 0.585 | 0.554 | 0 | 0 |
Long Term Investments
| 5.29 | 4.031 | 4.617 | 0.992 | 0.992 | 0.992 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | -0.992 | -0.992 | -0.992 | 0 | 0 |
Other Non-Current Assets
| 0.924 | 15.029 | 8.357 | 2.21 | 2.193 | 1.874 | 1.61 | 0.54 |
Total Non-Current Assets
| 90.334 | 57.876 | 57.516 | 46.177 | 53.116 | 31.922 | 28.821 | 8.03 |
Total Assets
| 177.769 | 240.754 | 278.106 | 221.567 | 184.389 | 189.558 | 117.3 | 46.421 |
Liabilities & Equity: | ||||||||
Current Liabilities: | ||||||||
Account Payables
| 3.819 | 8.694 | 4.23 | 9.578 | 4.621 | 4.825 | 3.935 | 0.762 |
Short Term Debt
| 6.904 | 5.294 | 7.483 | 5.874 | 2.505 | 0 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 2.35 | 5.131 | 17.201 | 3.475 | 4.956 | 5.34 | 0 | 0 |
Other Current Liabilities
| 14.266 | 15.682 | 11.042 | 8.061 | 7.418 | 4.943 | 3.717 | 1.732 |
Total Current Liabilities
| 27.339 | 34.801 | 39.956 | 26.988 | 19.5 | 15.108 | 7.652 | 2.494 |
Non-Current Liabilities: | ||||||||
Long Term Debt
| 40.144 | 35.022 | 18.936 | 19.225 | 20.985 | 10.49 | 10.521 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 3.128 | 8.22 | 9.56 | 13.473 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | -3.128 | 0 | -9.56 | 1.353 | 0 | 0 |
Other Non-Current Liabilities
| 58.436 | 0.15 | 3.128 | 0.395 | 9.56 | 0.012 | 1.845 | 2.238 |
Total Non-Current Liabilities
| 98.58 | 35.172 | 22.064 | 27.84 | 30.545 | 25.328 | 12.366 | 2.238 |
Total Liabilities
| 125.919 | 69.973 | 62.02 | 54.828 | 50.045 | 40.436 | 20.018 | 4.732 |
Equity: | ||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 156.937 | 61.139 |
Common Stock
| 0.022 | 0.022 | 0.02 | 0.018 | 0.017 | 0.016 | 0.001 | 0.001 |
Retained Earnings
| -659.561 | -521.071 | -401.384 | -326.302 | -220.988 | -126.402 | -61.627 | -20.25 |
Accumulated Other Comprehensive Income/Loss
| 0.003 | -0.08 | -0.073 | 0 | 0.024 | -0.085 | -0.074 | -0.003 |
Other Total Stockholders Equity
| 711.386 | 691.91 | 617.523 | 493.023 | 355.291 | 275.593 | 2.045 | 0.802 |
Total Shareholders Equity
| 51.85 | 170.781 | 216.086 | 166.739 | 134.344 | 149.122 | 97.282 | 41.689 |
Total Equity
| 51.85 | 170.781 | 216.086 | 166.739 | 134.344 | 149.122 | 97.282 | 41.689 |
Total Liabilities & Shareholders Equity
| 177.769 | 240.754 | 278.106 | 221.567 | 184.389 | 189.558 | 117.3 | 46.421 |